Provided by Tiger Fintech (Singapore) Pte. Ltd.

VistaGen Therapeutics

2.79
+0.02000.72%
Post-market: 2.790.00000.00%19:28 EDT
Volume:82.53K
Turnover:229.28K
Market Cap:80.53M
PE:-1.80
High:2.81
Open:2.77
Low:2.73
Close:2.77
1D
5D
D
W
M
Q
Y
1m
5m
10m
15m
30m
1h
2h
More
1D
5D
D
W
M
Q
Y
1m
5m
10m
15m
30m
1h
2h
Loading ...

BRIEF-Vistagen Announces Positive Results from Exploratory Phase 2A Study of PH284 in Cancer Cachexia

Reuters
·
14 Jan

Vistagen Therapeutics Inc - Phase 2a Study Evaluates Efficacy, Safety, and Tolerability of Ph284

THOMSON REUTERS
·
14 Jan

Vistagen Announces Positive Results From Exploratory Phase 2a Study of Ph284 in Cancer Cachexia

THOMSON REUTERS
·
14 Jan

Vistagen Therapeutics Inc - Ph284 Demonstrates No Serious Adverse Events

THOMSON REUTERS
·
14 Jan

BRIEF-Vistagen Initiates Fasedienol Repeat Dose Study For The Acute Treatment Of Social Anxiety Disorder

Reuters
·
10 Jan

Vistagen Initiates Fasedienol Repeat Dose Study for the Acute Treatment of Social Anxiety Disorder

THOMSON REUTERS
·
10 Jan

Vistagen Initiates Fasedienol Repeat Dose Study for the Acute Treatment of Social Anxiety Disorder

Business Wire
·
10 Jan

VistaGen Therapeutics Advances Neurocircuitry Treatments

TIPRANKS
·
06 Dec 2024

Stifel Nicolaus Sticks to Their Buy Rating for VistaGen Therapeutics (VTGN)

TIPRANKS
·
21 Nov 2024

VistaGen Therapeutics’ Promising Clinical Progress and Strong Financial Position Justify Buy Rating

TIPRANKS
·
09 Nov 2024

Vistagen Therapeutics Inc (VTGN) Q2 2025 Earnings Call Highlights: Navigating Challenges with a ...

GuruFocus.com
·
08 Nov 2024

VistaGen Therapeutics, Inc. (VTGN) Reports Q2 Loss, Misses Revenue Estimates

Zacks
·
08 Nov 2024

VistaGen Therapeutics Q2 2025 GAAP EPS $(0.42) Misses $(0.39) Estimate, Sales $183.000K Miss $223.333K Estimate

Benzinga
·
08 Nov 2024

Vistagen Therapeutics Inc - Qtrly Shr Loss $0.42

THOMSON REUTERS
·
07 Nov 2024

Vistagen Reports Fiscal Year 2025 Second Quarter Financial Results and Corporate Update

THOMSON REUTERS
·
07 Nov 2024

Vistagen Reports Fiscal Year 2025 Second Quarter Financial Results and Corporate Update

Business Wire
·
07 Nov 2024

If the download button clicks without skipping, click on the top right menu and select "Open in Browser."